NewGenIvf Group (NASDAQ:NIVF) and DocGo (NASDAQ:DCGO) Head-To-Head Contrast

DocGo (NASDAQ:DCGO) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares DocGo and NewGenIvf Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DocGo	-14.02%	-9.11%	-6.44%
NewGenIvf Group	N/A	N/A	N/A

Volatility and Risk

DocGo has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.12, suggesting that its share price is 112% less volatile than the S&P 500.

Institutional and Insider Ownership

56.4% of DocGo shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 3.8% of DocGo shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares DocGo and NewGenIvf Group”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$616.55 million	0.16	$19.99 million	($0.52)	-1.98
NewGenIvf Group	$5.43 million	0.20	-$520,000.00	N/A	N/A

DocGo has higher revenue and earnings than NewGenIvf Group.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for DocGo and NewGenIvf Group, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1	4	2	0	2.14
NewGenIvf Group	1	0	0	0	1.00

DocGo presently has a consensus target price of $3.21, suggesting a potential upside of 211.89%. Given DocGo’s stronger consensus rating and higher possible upside, research analysts plainly believe DocGo is more favorable than NewGenIvf Group.

About DocGo

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

About NewGenIvf Group

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.